|
Volumn 42, Issue 5, 1998, Pages 677-678
|
Can a single antibiotic policy for the empirical treatment of febrile neutropenic patients be used for all categories of haematology/oncology patient in the same institution? [7]
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIINFECTIVE AGENT;
AZLOCILLIN;
CIPROFLOXACIN;
FLUCONAZOLE;
GENTAMICIN;
MEROPENEM;
PENICILLIN G;
PENICILLIN V;
VANCOMYCIN;
ANTIBIOTIC SENSITIVITY;
BACTEREMIA;
BLOOD CULTURE;
ENTEROBACTERIACEAE;
GRAM POSITIVE BACTERIUM;
HEALTH CARE POLICY;
HUMAN;
LETTER;
NEUTROPENIA;
NEUTROPHIL;
PSEUDOMONAS AERUGINOSA;
TIME;
ADULT;
ANTI-BACTERIAL AGENTS;
BACTEREMIA;
CHILD;
DRUG UTILIZATION;
FEVER;
HEMATOLOGIC DISEASES;
HUMANS;
MICROBIAL SENSITIVITY TESTS;
NEOPLASMS;
NEUTROPENIA;
|
EID: 0031739654
PISSN: 03057453
EISSN: None
Source Type: Journal
DOI: 10.1093/jac/42.5.677 Document Type: Letter |
Times cited : (2)
|
References (5)
|